Index S&P 500
P/E 51.43
EPS (ttm) 4.54
Insider Own 0.14%
Shs Outstand 290.39M
Perf Week -2.87%
Market Cap 67.55B
Forward P/E 16.38
EPS next Y 14.27
Insider Trans -2.15%
Shs Float 288.61M
Perf Month -1.50%
Income 1.32B
PEG 5.98
EPS next Q 3.31
Inst Own 87.64%
Short Float 0.77%
Perf Quarter -1.26%
Sales 19.72B
P/S 3.43
EPS this Y 6.89%
Inst Trans -1.90%
Short Ratio 1.58
Perf Half Y -2.80%
Book/sh 88.74
P/B 2.63
EPS next Y 9.33%
ROA 2.54%
Short Interest 2.23M
Perf Year -7.74%
Cash/sh 11.14
P/C 20.97
EPS next 5Y 8.60%
ROE 5.37%
52W Range 224.00 - 287.32
Perf YTD -4.14%
Dividend Est. 3.78 (1.62%)
P/FCF 22.32
EPS past 5Y 52.43%
ROI 3.17%
52W High -18.65%
Beta 0.43
Dividend TTM 3.76 (1.61%)
Quick Ratio 0.97
Sales past 5Y 4.18%
Gross Margin 41.25%
52W Low 4.34%
ATR (14) 4.06
Dividend Ex-Date Jun 10, 2024
Current Ratio 1.41
EPS Y/Y TTM -16.60%
Oper. Margin 12.43%
RSI (14) 47.93
Volatility 1.49% 1.60%
Employees 73000
Debt/Eq 0.70
Sales Y/Y TTM 4.82%
Profit Margin 6.68%
Recom 1.63
Target Price 278.03
Option/Short Yes / Yes
LT Debt/Eq 0.62
EPS Q/Q 20.61%
Payout 73.72%
Rel Volume 0.65
Prev Close 231.97
Sales Surprise 0.15%
EPS Surprise 6.77%
Sales Q/Q 4.65%
Earnings May 02 BMO
Avg Volume 1.42M
Price 233.73
SMA20 -0.20%
SMA50 -0.72%
SMA200 -4.18%
Trades
Volume 927,742
Change 0.76%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-24 Initiated
Goldman
Buy
$274
Jul-24-23 Upgrade
Raymond James
Mkt Perform → Outperform
$305
May-30-23 Resumed
Morgan Stanley
Overweight
$295
May-05-23 Upgrade
Piper Sandler
Neutral → Overweight
$260 → $290
Apr-12-23 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$304
Jan-03-23 Upgrade
BofA Securities
Neutral → Buy
$250 → $290
Dec-12-22 Upgrade
Citigroup
Sell → Neutral
$221 → $250
Jul-11-22 Downgrade
Citigroup
Neutral → Sell
$265 → $235
Jun-24-22 Upgrade
Wells Fargo
Equal Weight → Overweight
$275
Mar-18-22 Resumed
Raymond James
Mkt Perform
Mar-02-22 Resumed
BofA Securities
Neutral
$290
Dec-08-21 Downgrade
Piper Sandler
Overweight → Neutral
$285 → $260
Aug-06-21 Downgrade
JP Morgan
Overweight → Neutral
$265
May-25-21 Initiated
Barclays
Equal Weight
$270
Dec-15-20 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$297
Dec-15-20 Downgrade
Wells Fargo
Overweight → Equal Weight
$265
Jul-09-20 Upgrade
Barclays
Equal Weight → Overweight
$300
Jun-01-20 Resumed
Goldman
Buy
$278
Mar-05-20 Initiated
Citigroup
Neutral
$260
Feb-07-20 Downgrade
Raymond James
Strong Buy → Outperform
$283
Show Previous Ratings
Jun-10-24 07:01AM
Jun-06-24 02:31PM
02:25PM
Jun-05-24 12:18PM
Jun-04-24 04:45AM
04:30PM
Loading…
Jun-03-24 04:30PM
(Investor's Business Daily)
02:13PM
(The Wall Street Journal)
11:58AM
11:34AM
08:25AM
(The Wall Street Journal)
06:30AM
06:30AM
May-21-24 04:30PM
May-17-24 12:27PM
May-15-24 10:57AM
06:45AM
Loading…
06:45AM
May-06-24 10:51AM
06:51AM
May-03-24 11:39AM
07:08AM
03:01AM
01:07AM
May-02-24 10:26PM
(Thomson Reuters StreetEvents)
02:16PM
01:59PM
10:54AM
09:40AM
09:30AM
09:25AM
09:15AM
08:48AM
Loading…
08:48AM
07:52AM
07:40AM
07:25AM
07:18AM
06:41AM
(Associated Press Finance)
06:30AM
May-01-24 03:00PM
Apr-30-24 04:15PM
Apr-29-24 04:15PM
12:21PM
09:16AM
Apr-26-24 06:00AM
Apr-18-24 05:35AM
Apr-12-24 11:04AM
Apr-09-24 10:15AM
Apr-08-24 10:27AM
Apr-05-24 06:45AM
Apr-04-24 04:15PM
09:40AM
Apr-03-24 08:48PM
Apr-02-24 04:12PM
Mar-27-24 06:50AM
Mar-26-24 09:31AM
Mar-21-24 07:05AM
06:57AM
06:50AM
Mar-18-24 06:50AM
Mar-14-24 01:00PM
11:57AM
Mar-13-24 04:30PM
06:50AM
Mar-12-24 10:34AM
Mar-06-24 05:05AM
Mar-05-24 08:28AM
Mar-04-24 05:35PM
07:37AM
06:50AM
Feb-29-24 05:26AM
Feb-27-24 01:28PM
06:50AM
Feb-26-24 09:18AM
Feb-23-24 11:14AM
Feb-21-24 06:45AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
Feb-13-24 12:07PM
Feb-12-24 04:43PM
Feb-06-24 10:28AM
Feb-05-24 12:23AM
Feb-02-24 08:52AM
12:17AM
12:01AM
(Thomson Reuters StreetEvents)
Feb-01-24 01:11PM
10:35AM
10:01AM
09:30AM
07:40AM
07:20AM
07:03AM
06:36AM
(Associated Press Finance)
06:30AM
Jan-31-24 11:52AM
Jan-30-24 06:45AM
Jan-29-24 10:49AM
09:16AM
Jan-25-24 10:29AM
10:00AM
06:45AM
Jan-23-24 04:15PM
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Spoerel Thomas J SVP,Controller&Chief Acct Off Jun 10 '24 Sale 239.31 300 71,793 1,976 Jun 11 01:45 PM Goette Roland EVP and President EMEA May 15 '24 Sale 236.73 3,300 781,224 11,308 May 16 07:54 PM Goette Roland EVP and President EMEA May 13 '24 Sale 236.70 3,300 781,121 14,608 May 15 02:44 PM Garrison Michael David EVP & President Medical Apr 30 '24 Sale 232.81 1,715 399,269 5,381 May 01 12:59 PM Spoerel Thomas J SVP,Controller&Chief Acct Off Mar 14 '24 Sale 238.29 282 67,198 2,276 Mar 15 02:19 PM Garrison Michael David EVP & President Medical Dec 11 '23 Sale 232.46 1,239 288,018 7,274 Dec 12 04:31 PM Byrd Richard EVP & President Interventional Nov 28 '23 Sale 238.47 2,156 514,141 4,120 Nov 29 07:27 PM Goette Roland EVP and President, EMEA Nov 16 '23 Option Exercise 107.12 3,544 379,633 17,164 Nov 20 02:20 PM Byrd Richard EVP & President Interventional Sep 05 '23 Sale 274.48 459 125,986 3,444 Sep 06 09:32 AM Fraser Claire Director Aug 28 '23 Sale 281.66 848 238,848 21,608 Aug 30 08:48 AM Hickey David EVP & President, Life Sciences Aug 11 '23 Option Exercise 132.54 3,883 514,653 9,030 Aug 14 04:40 PM Hickey David EVP & President, Life Sciences Aug 11 '23 Sale 277.85 2,974 826,326 4,199 Aug 14 04:40 PM Garrison Michael David EVP & President Medical Aug 08 '23 Sale 277.13 1,300 360,269 5,157 Aug 09 02:41 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite